Display Settings:

Format
Sort by

Send to:

Choose Destination

Results: 3

1.

Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons.

Jackson LA, Gaglani MJ, Keyserling HL, Balser J, Bouveret N, Fries L, Treanor JJ.

BMC Infect Dis. 2010 Mar 17;10:71. doi: 10.1186/1471-2334-10-71.

PMID:
20236548
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

A vaccine manufacturer's approach to address medical needs related to seasonal and pandemic influenza viruses.

Baras B, Bouveret N, Devaster JM, Fries L, Gillard P, Sänger R, Hanon E.

Influenza Other Respir Viruses. 2008 Nov;2(6):251-60. doi: 10.1111/j.1750-2659.2008.00054.x. Review.

PMID:
19453402
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa.

Lee CH, Kuo WC, Beri S, Kapre S, Joshi JS, Bouveret N, LaForce FM, Frasch CE.

Vaccine. 2009 Jan 29;27(5):726-32. doi: 10.1016/j.vaccine.2008.11.065. Epub 2008 Dec 6.

PMID:
19063929
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk